Dätwyler Holding (DAE) Aktienübersicht
Die Dätwyler Holding AG produziert und vertreibt Elastomerkomponenten für das Gesundheitswesen, die Automobilindustrie, die Industrie sowie die Nahrungsmittel- und Getränkeindustrie in der Schweiz, im übrigen Europa, in Nord- und Südamerika, in Asien und international. Mehr Details
| Schneeflocken-Punktzahl | |
|---|---|
| Bewertung | 0/6 |
| Künftiges Wachstum | 3/6 |
| Vergangene Leistung | 4/6 |
| Finanzielle Gesundheit | 4/6 |
| Dividenden | 4/6 |
DAE Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Analyst Price Targets
CE
Ceazar
Community ContributorUS$3.87FV • 2.6% unterbewertet intrinsischer Abschlag
30972.3%Revenue growth p.a.
192
1
0
7
Dätwyler Holding AG Wettbewerber
Preisentwicklung & Leistung
| Historische Aktienkurse | |
|---|---|
| Aktueller Aktienkurs | CHF 157.00 |
| 52-Wochen-Hoch | CHF 171.60 |
| 52-Wochen-Tief | CHF 112.20 |
| Beta | 1.09 |
| 1 Monat Veränderung | 9.18% |
| 3 Monate Veränderung | -4.15% |
| 1 Jahr Veränderung | 31.05% |
| 3 Jahre Veränderung | -34.31% |
| 5 Jahre Veränderung | -46.78% |
| Veränderung seit IPO | 1,306.17% |
Aktuelle Nachrichten und Updates
DAE: Steady Outlook Will Reflect Balanced Assumptions And Stable Market Expectations
Analysts are maintaining their CHF 143.00 price target for Dätwyler Holding, as small adjustments to discount rate, revenue growth and profit margin assumptions are viewed as offsetting, alongside a slightly lower estimate for the future P/E multiple. Valuation Changes Fair Value: CHF 143.00 fair value estimate is unchanged, and the same target level is maintained.
DAE: Drug Delivery Collaboration Will Support Bullish Outlook On Future Earnings
Analysts have nudged their fair value estimate for Dätwyler Holding from CHF 178.00 to about CHF 179.67. This reflects slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a modestly higher price target in CHF terms.DAE: Drug Delivery Partnership Will Support Steady Outlook At Current Valuation
Analysts now hold Dätwyler Holding's fair value steady at about CHF 143, with only slight model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions driving a very marginal change in their overall price target stance. What's in the News Dätwyler Holding announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large-volume subcutaneous drug delivery through convenient on-body administration of larger doses for patients and market needs (Key Developments).DAE: Collaboration In Drug Delivery Will Support Steady Long Term Outlook
Analysts have raised their CHF price target on Dätwyler Holding from CHF129 to CHF143, citing updated assumptions for fair value, a slightly higher discount rate, adjusted revenue growth expectations, a modest change in profit margin outlook, and a revised future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group focused on large volume subcutaneous drug delivery and on-body administration solutions for patients using biologics and other sensitive therapies (Key Developments).Recent updates
DAE: Steady Outlook Will Reflect Balanced Assumptions And Stable Market Expectations
Analysts are maintaining their CHF 143.00 price target for Dätwyler Holding, as small adjustments to discount rate, revenue growth and profit margin assumptions are viewed as offsetting, alongside a slightly lower estimate for the future P/E multiple. Valuation Changes Fair Value: CHF 143.00 fair value estimate is unchanged, and the same target level is maintained.DAE: Drug Delivery Collaboration Will Support Bullish Outlook On Future Earnings
Analysts have nudged their fair value estimate for Dätwyler Holding from CHF 178.00 to about CHF 179.67. This reflects slightly adjusted assumptions for the discount rate, revenue growth, profit margin and future P/E that together support a modestly higher price target in CHF terms.DAE: Drug Delivery Partnership Will Support Steady Outlook At Current Valuation
Analysts now hold Dätwyler Holding's fair value steady at about CHF 143, with only slight model tweaks to the discount rate, revenue growth, profit margin and future P/E assumptions driving a very marginal change in their overall price target stance. What's in the News Dätwyler Holding announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large-volume subcutaneous drug delivery through convenient on-body administration of larger doses for patients and market needs (Key Developments).DAE: Collaboration In Drug Delivery Will Support Steady Long Term Outlook
Analysts have raised their CHF price target on Dätwyler Holding from CHF129 to CHF143, citing updated assumptions for fair value, a slightly higher discount rate, adjusted revenue growth expectations, a modest change in profit margin outlook, and a revised future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group focused on large volume subcutaneous drug delivery and on-body administration solutions for patients using biologics and other sensitive therapies (Key Developments).DAE: Outlook Will Balance Drug Delivery Collaboration With Moderated Profit Expectations
Analysts have raised their fair value estimate for Dätwyler Holding from CHF 158 to CHF 178, citing updated assumptions related to revenue growth, profit margins and a higher future P/E multiple. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large volume subcutaneous drug delivery, focusing on convenient on body administration that aims to meet evolving patient and market needs (Key Developments).Dätwyler Holding (VTX:DAE) Is Paying Out A Dividend Of CHF3.20
Feb 15
DAE: Large Volume Drug Delivery Collaboration Will Support Attractive Future Share Upside
Analysts have maintained their price target for Dätwyler Holding at CHF 185.00, citing slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E that fine tune rather than overhaul their prior view. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group aimed at broadening large volume subcutaneous drug delivery through convenient on body administration of larger doses to address evolving patient and market needs (Key Developments).DAE: Large Volume Drug Delivery Partnership Will Support Stable Future Share Performance
Analysts have kept their price target for Dätwyler Holding steady at CHF 185, citing only slight adjustments to assumptions around discount rate, revenue growth, profit margin and future P/E that did not materially alter their valuation view. What's in the News Dätwyler announced a collaboration with LTS Device Technologies and Stevanato Group to broaden large volume subcutaneous drug delivery through on body self administration solutions for patients and pharmaceutical customers (Key Developments).DAE: Higher Margin Outlook Will Support Stronger Future Share Performance
Analysts now place their fair value estimate for Dätwyler Holding at CHF 185, up from CHF 174, citing updated assumptions for revenue growth, profit margins, and future P/E levels. Valuation Changes Fair Value Estimate was raised from CHF 174 to CHF 185, indicating a modest upward adjustment in the intrinsic assessment.Is Dätwyler Holding AG (VTX:DAE) Worth CHF166 Based On Its Intrinsic Value?
Jan 07DAE: Higher Future Earnings Multiple Will Drive Stronger Share Performance
Analysts have raised their price target on Dätwyler Holding from CHF 143 to CHF 174, citing slightly firmer long term revenue growth expectations, improved profit margin forecasts, and a higher anticipated future valuation multiple. Valuation Changes Fair Value: increased from CHF 143 to CHF 174, representing a material upward revision to the target level.Dätwyler Holding AG's (VTX:DAE) Popularity With Investors Is Under Threat From Overpricing
Dec 04DAE: Outlook Will Balance Faster Revenue Outlook With Modestly Higher Profit Margins
Analysts have raised their price target for Dätwyler Holding from CHF 144.25 to CHF 158.00, reflecting increased confidence in faster revenue growth, slightly higher profit margins, and a modestly richer future earnings multiple. Valuation Changes The Fair Value Estimate has risen moderately from CHF 144.25 to CHF 158.00, suggesting a higher intrinsic value assessment for Dätwyler Holding.DAE: Updated Fair Value Reflects Balanced Outlook Amid Rate Adjustments
Analysts have raised their fair value estimate for Dätwyler Holding from CHF 138 to CHF 144.25. They cite updated assumptions around revenue growth, profit margins, and discount rates as reasons for this change.At CHF148, Is It Time To Put Dätwyler Holding AG (VTX:DAE) On Your Watch List?
Oct 07Dätwyler Holding AG's (VTX:DAE) Intrinsic Value Is Potentially 33% Above Its Share Price
Sep 22High-value Healthcare And Electric Vehicles Will Transform Future Markets
The notable reduction in Dätwyler Holding's consensus analyst price target is primarily driven by a significant decrease in its future P/E multiple, with fair value now revised downward to CHF138.00. Valuation Changes Summary of Valuation Changes for Dätwyler Holding The Consensus Analyst Price Target has significantly fallen from CHF154.20 to CHF138.00.These 4 Measures Indicate That Dätwyler Holding (VTX:DAE) Is Using Debt Reasonably Well
Aug 11Dätwyler Holding AG's (VTX:DAE) Shares Climb 26% But Its Business Is Yet to Catch Up
Jul 26Should You Think About Buying Dätwyler Holding AG (VTX:DAE) Now?
Jul 08Dätwyler Holding AG's (VTX:DAE) Earnings Haven't Escaped The Attention Of Investors
May 13Is Now An Opportune Moment To Examine Dätwyler Holding AG (VTX:DAE)?
Apr 03Dätwyler Holding's (VTX:DAE) Dividend Will Be CHF3.20
Mar 19
ForwardNow Will Streamline Operations, Focusing On High-Margin Products And Sustainable Practices
The ForwardNow program's optimization and focus on high-margin products aim to boost profitability and net margins.Is Dätwyler Holding (VTX:DAE) Using Too Much Debt?
Mar 01Dätwyler Holding's (VTX:DAE) Soft Earnings Are Actually Better Than They Appear
Feb 14Dätwyler Holding AG (VTX:DAE) Shares Could Be 39% Below Their Intrinsic Value Estimate
Dec 13Dätwyler Holding AG (VTX:DAE) Not Lagging Market On Growth Or Pricing
Nov 06Dätwyler Holding AG (VTX:DAE) Just Released Its Interim Earnings: Here's What Analysts Think
Jul 27Estimating The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Jul 17Is There Now An Opportunity In Dätwyler Holding AG (VTX:DAE)?
Jun 13Does Dätwyler Holding (VTX:DAE) Have A Healthy Balance Sheet?
Apr 17A Look At The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Apr 01Dätwyler Holding's (VTX:DAE) Dividend Will Be CHF3.20
Mar 17Earnings Miss: Dätwyler Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 10Is It Time To Consider Buying Dätwyler Holding AG (VTX:DAE)?
Feb 05Dätwyler Holding AG's (VTX:DAE) P/E Is On The Mark
Dec 22Is Dätwyler Holding (VTX:DAE) A Risky Investment?
Nov 03Is Now An Opportune Moment To Examine Dätwyler Holding AG (VTX:DAE)?
Oct 19A Look At The Fair Value Of Dätwyler Holding AG (VTX:DAE)
Aug 12Dätwyler Holding (VTX:DAE) Seems To Use Debt Quite Sensibly
Jul 25What Does Dätwyler Holding AG's (VTX:DAE) Share Price Indicate?
May 20Is Dätwyler Holding (VTX:DAE) A Risky Investment?
Apr 10When Should You Buy Dätwyler Holding AG (VTX:DAE)?
Feb 10Is Dätwyler Holding (VTX:DAE) Using Too Much Debt?
Dec 29At CHF181, Is It Time To Put Dätwyler Holding AG (VTX:DAE) On Your Watch List?
Oct 29Does Dätwyler Holding (VTX:DAE) Have A Healthy Balance Sheet?
Sep 20Aktionärsrenditen
| DAE | CH Machinery | CH Markt | |
|---|---|---|---|
| 7D | 2.1% | -0.7% | -0.3% |
| 1Y | 31.1% | -4.3% | 7.0% |
Rendite im Vergleich zur Industrie: DAE übertraf die Branche Swiss Machinery , die im vergangenen Jahr eine Rendite von -4.3 erzielte.
Rendite vs. Markt: DAE übertraf den Markt Swiss, der im vergangenen Jahr eine Rendite von 7 erzielte.
Preisvolatilität
| DAE volatility | |
|---|---|
| DAE Average Weekly Movement | 4.0% |
| Machinery Industry Average Movement | 5.2% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in CH Market | 8.3% |
| 10% least volatile stocks in CH Market | 2.2% |
Stabiler Aktienkurs: DAE hatte in den letzten 3 Monaten im Vergleich zum Swiss -Markt keine signifikante Preisvolatilität.
Volatilität im Zeitverlauf: DAEDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen
| Gegründet | Mitarbeiter | CEO | Website |
|---|---|---|---|
| 1915 | 7,823 | Volker Cwielong | www.datwyler.com |
Die Dätwyler Holding AG produziert und vertreibt Elastomerkomponenten für das Gesundheitswesen, die Automobilindustrie, die Industrie sowie die Nahrungsmittel- und Getränkeindustrie in der Schweiz, im übrigen Europa, in Nord- und Südamerika, in Asien und international. Das Unternehmen ist in zwei Sparten tätig, Healthcare und Industrial. Die Sparte Healthcare bietet Gummikomponenten für vorgefüllte Spritzen, Pens und Injektionssysteme, Komponenten und Verschlüsse für injizierbare Medikamente in Fläschchen sowie Gummikomponenten für Blutentnahmesysteme, IV-Verabreichungssets, Einwegspritzen, diagnostische und medizinische Geräte usw.
Dätwyler Holding AG's Grundlagenzusammenfassung
| DAE grundlegende Statistiken | |
|---|---|
| Marktanteil | CHF 2.67b |
| Gewinn(TTM) | CHF 80.80m |
| Umsatz(TTM) | CHF 1.10b |
33.0x
Kurs-Gewinn-Verhältnis 2.4x
Kurs-Umsatz-VerhältnisIst DAE zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
| DAE Gewinn- und Verlustrechnung (TTM) | |
|---|---|
| Einnahmen | CHF 1.10b |
| Kosten der Einnahmen | CHF 842.60m |
| Bruttogewinn | CHF 257.90m |
| Sonstige Ausgaben | CHF 177.10m |
| Gewinn | CHF 80.80m |
Zuletzt gemeldete Gewinne
Dec 31, 2025
Datum des nächsten Gewinnberichts
Jul 23, 2026
| Gewinn per Aktie (EPS) | 4.75 |
| Bruttomarge | 23.43% |
| Nettogewinnspanne | 7.34% |
| Schulden/Eigenkapital-Verhältnis | 136.6% |
Wie hat sich DAE auf lange Sicht entwickelt?
Historische Performance und VergleicheDividenden
2.0%
Aktuelle Dividendenrendite67%
AusschüttungsquoteUnternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/03 22:44 |
| Aktienkurs zum Tagesende | 2026/04/30 00:00 |
| Gewinne | 2025/12/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Dätwyler Holding AG wird von 6 Analysten beobachtet. 6 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Benjamin Thielmann | Berenberg |
| Savana Lamce | Research Partners AG |
| Michael Inauen | Stifel, Equities Research |